Bio-techne Corp. Earnings

Bio-techne Corp.’s revenue jumped 4.2% since last year same period to $316.18Mn in the Q1 2025. On a quarterly growth basis, Bio-techne Corp. has generated 6.45% jump in its revenue since last 3-months.

Bio-techne Corp.’s net profit fell -53.96% since last year same period to $22.59Mn in the Q1 2025. On a quarterly growth basis, Bio-techne Corp. has generated -35.26% fall in its net profits since last 3-months.

Bio-techne Corp.’s net profit margin fell -55.81% since last year same period to 7.14% in the Q1 2025. On a quarterly growth basis, Bio-techne Corp. has generated -39.18% fall in its net profit margins since last 3-months.

Bio-techne Corp.’s price-to-earnings ratio after this Q1 2025 earnings stands at 63.36.

Bio-techne Corp.’s earning per share (EPS) estimates for the current quarter stand at 0.44 - a -12.39% fall from last quarter’s estimates.

Bio-techne Corp.’s earning per share (EPS) estimates for the current year stand at 0.44.

Bio-techne Corp.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2025. This indicates that the Bio-techne Corp. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Bio-techne Corp. declared 0.08 dividend per share during the earnings announcement for Q2 2025.